NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ)
$157.1 1.27 (0.815%)
Analysed NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) News Sources
CrowdStrike Leads This Group Of Four Stocks To New Highs
15-05-2026
yahoo.com
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics
18-05-2026
yahoo.com
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules
18-05-2026
yahoo.com
Bausch Health Announces 2026 Annual Meeting of Shareholder Results
19-05-2026
yahoo.com
Neurocrine Biosciences Hits New Highs On Earnings Surge
20-05-2026
yahoo.com
A Look At Neurocrine Biosciences (NBIX) Valuation As New INGREZZA Real World Data Gains Attention
21-05-2026
yahoo.com
Will New Real-World INGREZZA (valbenazine) Data in Mild TD Change Neurocrine Biosciences' (NBIX) Narrative
21-05-2026
yahoo.com
Bernstein Initiates Coverage of Neurocrine Biosciences (NBIX) with Outperform
25-05-2026
yahoo.com
US High Growth Tech Stocks To Watch Now
26-05-2026
yahoo.com
Neurocrine Biosciences to Present at Upcoming Investor Conferences in June
26-05-2026
yahoo.com
What is the current price of NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ)?
The current price of NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) is $157.1.
NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) since the previous trading day is $1.27.
NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) since the previous trading day is 0.815%.
What is the most recent average sentiment score for NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ)?
The most recent average sentiment score for NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ)?
The most recent sentiment for NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ) is .
SEC-8K** Filing Available For NEUROCRINE BIOSCIENCES INC (NBIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.